Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High Efficacy of Saliva in Detecting SARS-CoV-2 by RT-PCR in Adults and Children.
Huber M, Schreiber PW, Scheier T, Audigé A, Buonomano R, Rudiger A, Braun DL, Eich G, Keller DI, Hasse B, Böni J, Berger C, Günthard HF, Manrique A, Trkola A. Huber M, et al. Among authors: audige a. Microorganisms. 2021 Mar 19;9(3):642. doi: 10.3390/microorganisms9030642. Microorganisms. 2021. PMID: 33808815 Free PMC article.
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin's lymphoma.
Muller CKS, Spagnuolo J, Audigé A, Chancellor A, Russenberger D, Scherrer AU, Hoffmann M, Kouyos R, Battegay M, De Libero G, Speck RF; Swiss HIV Cohort Study. Muller CKS, et al. Among authors: audige a. Infect Agent Cancer. 2021 Apr 17;16(1):24. doi: 10.1186/s13027-021-00365-4. Infect Agent Cancer. 2021. PMID: 33865435 Free PMC article.
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity.
Abela IA, Pasin C, Schwarzmüller M, Epp S, Sickmann ME, Schanz MM, Rusert P, Weber J, Schmutz S, Audigé A, Maliqi L, Hunziker A, Hesselman MC, Niklaus CR, Gottschalk J, Schindler E, Wepf A, Karrer U, Wolfensberger A, Rampini SK, Meyer Sauteur PM, Berger C, Huber M, Böni J, Braun DL, Marconato M, Manz MG, Frey BM, Günthard HF, Kouyos RD, Trkola A. Abela IA, et al. Among authors: audige a. Nat Commun. 2021 Nov 18;12(1):6703. doi: 10.1038/s41467-021-27040-x. Nat Commun. 2021. PMID: 34795285 Free PMC article.
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation.
Huang A, Cicin-Sain C, Pasin C, Epp S, Audigé A, Müller NJ, Nilsson J, Bankova A, Wolfensberger N, Vilinovszki O, Nair G, Hockl P, Schanz U, Kouyos RD, Hasse B, Zinkernagel AS, Trkola A, Manz MG, Abela IA, Müller AMS. Huang A, et al. Among authors: audige a. Transplant Cell Ther. 2022 Apr;28(4):214.e1-214.e11. doi: 10.1016/j.jtct.2022.01.019. Epub 2022 Jan 31. Transplant Cell Ther. 2022. PMID: 35092892 Free PMC article.
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.
Speich B, Chammartin F, Abela IA, Amico P, Stoeckle MP, Eichenberger AL, Hasse B, Braun DL, Schuurmans MM, Müller TF, Tamm M, Audigé A, Mueller NJ, Rauch A, Günthard HF, Koller MT, Trkola A, Briel M, Kusejko K, Bucher HC; Swiss HIV Cohort Study and the Swiss Transplant Cohort Study. Speich B, et al. Among authors: audige a. Clin Infect Dis. 2022 Aug 24;75(1):e585-e593. doi: 10.1093/cid/ciac169. Clin Infect Dis. 2022. PMID: 35234868 Free PMC article. Clinical Trial.
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response.
Marconato M, Abela IA, Hauser A, Schwarzmüller M, Katzensteiner R, Braun DL, Epp S, Audigé A, Weber J, Rusert P, Schindler E, Pasin C, West E, Böni J, Kufner V, Huber M, Zaheri M, Schmutz S, Frey BM, Kouyos RD, Günthard HF, Manz MG, Trkola A. Marconato M, et al. Among authors: audige a. J Clin Invest. 2022 Jun 15;132(12):e158190. doi: 10.1172/JCI158190. J Clin Invest. 2022. PMID: 35482408 Free PMC article. Clinical Trial.
Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation.
Bankova AK, Pasin C, Huang A, Cicin-Sain C, Epp S, Audige A, Mueller NJ, Nilsson J, Vilinovszki O, Nair G, Wolfensberger N, Hockl P, Schanz U, Trkola A, Kouyos R, Hasse B, Zinkernagel AS, Manz MG, Abela IA, Müller AMS. Bankova AK, et al. Among authors: audige a. Br J Haematol. 2023 Apr;201(1):58-63. doi: 10.1111/bjh.18562. Epub 2022 Nov 16. Br J Haematol. 2023. PMID: 36382698 Free article.
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2).
Griessbach A, Chammartin F, Abela IA, Amico P, Stoeckle MP, Eichenberger AL, Hasse B, Braun DL, Schuurmans MM, Müller TF, Tamm M, Audigé A, Mueller NJ, Rauch A, Günthard HF, Koller MT, Trkola A, Epp S, Amstutz A, Schönenberger CM, Taji Heravi A, Kusejko K, Bucher HC, Briel M, Speich B; Swiss HIV Cohort Study and the Swiss Transplant Cohort Study. Griessbach A, et al. Among authors: audige a. Open Forum Infect Dis. 2023 Mar 30;10(4):ofad150. doi: 10.1093/ofid/ofad150. eCollection 2023 Apr. Open Forum Infect Dis. 2023. PMID: 37035486 Free PMC article.
Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1.
Chammartin F, Griessbach A, Kusejko K, Audigé A, Epp S, Stoeckle MP, Eichenberger AL, Amstutz A, Schoenenberger CM, Hasse B, Braun DL, Rauch A, Trkola A, Briel M, Bucher HC, Günthard HF, Speich B, Abela IA; Swiss HIV Cohort Study. Chammartin F, et al. Among authors: audige a. AIDS. 2024 Feb 1;38(2):217-222. doi: 10.1097/QAD.0000000000003751. Epub 2023 Oct 11. AIDS. 2024. PMID: 37830908
36 results